Gerald Illerhaus
5PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jul 28, 2023
The JAK1/2 inhibitor ruxolitinib in patients with COVID-19 triggered hyperinflammation: the RuxCoFlam trial.J Hammersen, S Birndt, K Döhner
|Jun 15, 2023
Primary central nervous system lymphoma.Andrés J M Ferreri, Teresa Calimeri, Kate Cwynarski
|Sep 10, 2022
Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphoma.Julia Wendler, Christopher P Fox, Elke Valk
|Jul 24, 2018
A significant proportion of patients with primary central nervous system lymphoma harbor clonal bone marrow B-cells.Anna Brandt, Jakob Matschke, Wilfried Fehrle
Pageof 1
